Literature DB >> 14609125

Cholinesterase inhibitory activity of two farnesylacetone derivatives from the brown alga Sargassum sagamianum.

Geonseek Ryu1, Soo Hee Park, Eun Sook Kim, Byoung Wook Choi, Shi Yong Ryu, Bong Ho Lee.   

Abstract

Two known farnesylacetone derivatives (1 and 2) were isolated from the Korean brown alga Sargassum sagamianum off Jeju Island, Korea. Compounds 1 and 2 were identified as (5E,10Z)-6,10,14-trimethylpentadeca-5,10-dien-2,12-dione and (5E,9E,13E)-6,10,4-trimethyl-pentadeca-5,9,13-trien-2,12-dione, respectively, by comparison with the literature data. Compounds 1 and 2 showed moderate acetylcholinesterase and butyrylcholinesterase inhibitory activities with IC50 values of 65.0 approximately 48.0 and 34.0 approximately 23.0 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609125     DOI: 10.1007/bf02980022

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  10 in total

1.  Natural Modulators of Amyloid-Beta Precursor Protein Processing.

Authors:  C Zhang; R E Tanzi
Journal:  Curr Alzheimer Res       Date:  2012-09-13       Impact factor: 3.498

Review 2.  The major bioactive components of seaweeds and their mosquitocidal potential.

Authors:  Ke-Xin Yu; Ibrahim Jantan; Rohani Ahmad; Ching-Lee Wong
Journal:  Parasitol Res       Date:  2014-08-14       Impact factor: 2.289

Review 3.  Therapeutic potential and health benefits of Sargassum species.

Authors:  Subhash R Yende; Uday N Harle; Bhupal B Chaugule
Journal:  Pharmacogn Rev       Date:  2014-01

4.  Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-β aggregation inhibitors.

Authors:  Shana V Stoddard; Mark T Hamann; Randy M Wadkins
Journal:  Mar Drugs       Date:  2014-04-04       Impact factor: 5.118

Review 5.  Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.

Authors:  Mariana Barbosa; Patrícia Valentão; Paula B Andrade
Journal:  Mar Drugs       Date:  2014-09-25       Impact factor: 5.118

6.  Gelidiella acerosa protects against Aβ 25-35-induced toxicity and memory impairment in Swiss Albino mice: an in vivo report.

Authors:  Syad Arif Nisha; Kasi Pandima Devi
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 7.  Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances.

Authors:  Md Abdul Hannan; Raju Dash; Md Nazmul Haque; Md Mohibbullah; Abdullah Al Mamun Sohag; Md Ataur Rahman; Md Jamal Uddin; Mahboob Alam; Il Soo Moon
Journal:  Mar Drugs       Date:  2020-07-01       Impact factor: 5.118

Review 8.  The Seaweed Diet in Prevention and Treatment of the Neurodegenerative Diseases.

Authors:  Leonel Pereira; Ana Valado
Journal:  Mar Drugs       Date:  2021-02-26       Impact factor: 5.118

9.  Assessment of mutagenic effect of G. acerosa and S. wightii in S. typhimurium (TA 98, TA 100, and TA 1538 strains) and evaluation of their cytotoxic and genotoxic effect in human mononuclear cells: a non-clinical study.

Authors:  Arif Nisha Syad; Pandima Devi Kasi
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

Review 10.  Secondary Metabolites and Biological Activity of Invasive Macroalgae of Southern Europe.

Authors:  Patrícia Máximo; Luísa M Ferreira; Paula Branco; Pedro Lima; Ana Lourenço
Journal:  Mar Drugs       Date:  2018-08-02       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.